Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
VevaRX review
Its own semaglutide page gives two different prices for the same product. The pricing cards read $189 a month or $399 for three months, and the paragraph directly beneath reads $167 a month or $467 for three — and since $467 is the tirzepatide total, the text appears to be leftover copy from the other product. The tirzepatide page has an arithmetic problem of its own, advertising $467 as equivalent to $149 a month when three months at $467 is $155.67, and there is no monthly tirzepatide plan: a three-month minimum applies and renews quarterly. The terms compound it by referring repeatedly to a different company's website and listing prices matching nothing on the product pages. What is genuinely strong is easy to miss underneath. VevaRX enumerates thirty-six states by name, locks the price before intake and holds it at every dose, and the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping — the only delivery timeline any seller in this batch publishes.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
VevaRX at a glance
- Semaglutide
- $189/mo
- Tirzepatide
- $155.67/mo, sold only as a 3-month plan
- Coverage
- 36 states, enumerated
- Start
- 2–3 days' shipping once approved
How we scored VevaRX
Each factor is read off VevaRX's published pricing, disclosures and intake flow, and the six roll up into the 56/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The weakest showing on speed — a slow published timeline, or none at all.
Tiered or opaque — the true monthly is hard to pin down up front.
The hardest start to fit around a workday — a scheduled visit, or no published answer either way.
Limited or state-gated availability — confirm yours first.
Not a two-molecule plan on the published facts — switching may mean starting again elsewhere.
Exit terms are the weak point: lock-in, notice periods, or a cancellation path that isn't published.
How we verified this review
- Last verified
- September 2026
- Confidence
- medium
- Primary source
- vevarx.com
Its own semaglutide page gives two different prices for the same product. The cards say $189 a month or $399 for three months; the paragraph beneath says $167 a month or $467 for three — and $467 is the tirzepatide price, so the text appears left over from the other product. The tirzepatide page advertises $467 as equivalent to $149 a month when it is $155.67. There is no monthly tirzepatide plan. The terms then refer repeatedly to a different company's website. Thirty-six states are enumerated, which is a real strength.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideMonthly planThe monthly card on the semaglutide page. The prose lower on that SAME page says the monthly program is $167, so the site gives two different monthly prices for one product. | $189 | Monthly planThe monthly card on the semaglutide page. The prose lower on that SAME page says the monthly program is $167, so the site gives two different monthly prices for one product. |
| Compounded semaglutide3-month plan, one charge of $399Labeled BEST VALUE and "Equivalent to $133/month". The prose below instead describes a 3-month program at $467, which is the tirzepatide total. | $133 | 3-month plan, one charge of $399Labeled BEST VALUE and "Equivalent to $133/month". The prose below instead describes a 3-month program at $467, which is the tirzepatide total. |
| Compounded tirzepatide3-month plan, one charge of $467 — the only optionAdvertised as "Equivalent to $149 per month", but $467 across three months is $155.67. There is no monthly tirzepatide plan; a three-month minimum applies and it renews every three months. | $156 | 3-month plan, one charge of $467 — the only optionAdvertised as "Equivalent to $149 per month", but $467 across three months is $155.67. There is no monthly tirzepatide plan; a three-month minimum applies and it renews every three months. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are VevaRX's public disclosures at last review and change often; confirm the current number on VevaRX's own site.
What we like
- Thirty-six states enumerated by name
- The price is locked in before intake and holds at every dose
- The quoted figure includes the provider visit, supplies and free two-to-three-day shipping
- The only seller in this batch to publish any delivery timeline
The caveats
- The semaglutide page states two different monthly prices, $189 and $167, for one product
- It also states two different three-month totals, $399 and $467, one of them the tirzepatide price
- Tirzepatide advertised as $149 a month when $467 over three months is $155.67
- No monthly tirzepatide option — a three-month minimum that renews quarterly
- The terms repeatedly reference a different company's website
- No compounding pharmacy named; nothing addresses pregnancy or postpartum timing
VevaRX for working moms: our verdict
Its own semaglutide page gives two different prices for the same product. The pricing cards read $189 a month or $399 for three months, and the paragraph directly beneath reads $167 a month or $467 for three — and since $467 is the tirzepatide total, the text appears to be leftover copy from the other product. The tirzepatide page has an arithmetic problem of its own, advertising $467 as equivalent to $149 a month when three months at $467 is $155.67, and there is no monthly tirzepatide plan: a three-month minimum applies and renews quarterly. The terms compound it by referring repeatedly to a different company's website and listing prices matching nothing on the product pages. What is genuinely strong is easy to miss underneath. VevaRX enumerates thirty-six states by name, locks the price before intake and holds it at every dose, and the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping — the only delivery timeline any seller in this batch publishes. It runs about $189/month, flat across every dose.
We weigh VevaRX the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What VevaRX will cost you
- Compounded semaglutide — Monthly plan: $189/mo
- Compounded semaglutide — 3-month plan, one charge of $399: $133/mo
- Compounded tirzepatide — 3-month plan, one charge of $467 — the only option: $156/mo
That's roughly in line with the ~$179/month median across our roster.
The medications VevaRX prescribes
VevaRX prescribes semaglutide and tirzepatide — the two best-evidenced molecules in the class, and having both on one account matters because you can switch between them without re-enrolling or hunting down a new provider mid-plan. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where VevaRX fits — and where it doesn't — for working moms
Right for you if…
- you want a flat price that doesn't climb every time you titrate up a dose.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for working moms: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
VevaRX is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Someone who wants a price fixed before intake and held at every dose, and who will confirm the monthly figure in writing given the page states two.
Alternatives to VevaRX
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing VevaRX
Head-to-head & alternatives
VevaRX, answered
- What does semaglutide cost?
- The page gives two answers. Its pricing cards say $189 a month or $399 for three months; the paragraph immediately below says $167 a month or $467 for three. The $467 is the tirzepatide total, so the text looks like leftover copy. Get the figure confirmed in writing before paying.
- Is tirzepatide $149 a month?
- No. The plan is $467 for three months, which is $155.67 a month, not the $149 advertised beside it. It is the seller's own arithmetic on its own product page, and there is no monthly option to compare against — three months is the minimum and it renews quarterly.
- Why do the terms mention another company?
- Worth asking them. VevaRX's terms state transactions are conducted on a different company's website, and list prices matching nothing on the VevaRX product pages. Legal documents describing another brand's storefront do not tell you what you are agreeing to.
- What is genuinely good?
- Three things. Thirty-six states enumerated by name rather than an all-fifty claim. The price is locked in before intake and holds at every dose. And the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping — the only delivery timeline published by any seller in this batch.
Pricing, states and verification reflect VevaRX's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.